Physician_Profile_ID,Category,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID,Total_Amount_of_Payment_USDollars,Date_of_Payment,Category,Record_ID
107296,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,86.37,02/26/2014,GNRL,149518940
107296,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,68.50,03/05/2014,GNRL,148170648
107296,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,40.39,02/13/2014,GNRL,187773086
107296,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,28.68,01/09/2015,GNRL,260023242
107296,GNRL,"Novartis Vaccines and Diagnostics Inc",MA,100000000209,20.82,11/05/2013,GNRL,101745310
107296,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,19.41,11/21/2014,GNRL,156892728
107296,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,18.95,09/18/2014,GNRL,148879888
107296,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,18.30,07/14/2014,GNRL,156892734
107296,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,18.20,08/07/2014,GNRL,156892736
107296,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,17.80,12/06/2013,GNRL,14267272
107296,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,16.72,03/10/2015,GNRL,275832548
107296,GNRL,"Novo Nordisk Inc",NJ,100000000144,16.57,08/14/2014,GNRL,161990842
107296,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,15.97,10/04/2014,GNRL,148871632
107296,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,15.22,10/16/2014,GNRL,150147286
107296,GNRL,"Novo Nordisk Inc",NJ,100000000144,14.99,09/16/2014,GNRL,162094116
107296,GNRL,"Novo Nordisk Inc",NJ,100000000144,14.56,05/05/2014,GNRL,161352408
107296,GNRL,"Novo Nordisk Inc",NJ,100000000144,14.31,02/03/2015,GNRL,266078468
107296,GNRL,"Novo Nordisk Inc",NJ,100000000144,14.27,07/28/2014,GNRL,161812546
107296,GNRL,"Novo Nordisk Inc",NJ,100000000144,14.20,02/16/2015,GNRL,266295368
107296,GNRL,"Novo Nordisk Inc",NJ,100000000144,14.03,11/15/2014,GNRL,162236458
107296,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,14.00,06/11/2014,GNRL,199574776
107296,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,13.96,09/03/2014,GNRL,198723734
107296,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,13.91,11/06/2014,GNRL,156892746
107296,GNRL,"Novo Nordisk Inc",NJ,100000000144,13.83,10/06/2014,GNRL,162317712
107296,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.72,03/26/2014,GNRL,149388863
107296,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.68,02/27/2015,GNRL,260115658
107296,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.65,08/22/2014,GNRL,148904194
107296,GNRL,"Novo Nordisk Inc",NJ,100000000144,13.65,07/17/2014,GNRL,161770738
107296,GNRL,"Novo Nordisk Inc",NJ,100000000144,13.51,02/19/2015,GNRL,266187800
107296,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.45,11/06/2014,GNRL,150299066
107296,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,13.43,02/24/2015,GNRL,325871912
107296,GNRL,"Novo Nordisk Inc",NJ,100000000144,13.37,03/27/2015,GNRL,266471202
107296,GNRL,"Novo Nordisk Inc",NJ,100000000144,13.33,08/11/2014,GNRL,161857528
107296,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,13.18,02/04/2015,GNRL,275832550
107296,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.13,01/16/2015,GNRL,260111830
107296,GNRL,"Novo Nordisk Inc",NJ,100000000144,13.02,03/03/2015,GNRL,266477954
107296,GNRL,"Novo Nordisk Inc",NJ,100000000144,12.97,01/29/2015,GNRL,266145822
107296,GNRL,"Novo Nordisk Inc",NJ,100000000144,12.95,03/26/2015,GNRL,266554446
107296,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,12.94,10/05/2014,GNRL,156892742
107296,GNRL,"Arbor Pharmaceuticals, Inc.",GA,100000005507,12.92,04/22/2014,GNRL,217622942
107296,GNRL,"Novo Nordisk Inc",NJ,100000000144,12.91,09/05/2014,GNRL,162069118
107296,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,12.89,01/07/2015,GNRL,275832546
107296,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.84,01/09/2015,GNRL,260077462
107296,GNRL,"Novo Nordisk Inc",NJ,100000000144,12.71,06/16/2014,GNRL,161558998
107296,GNRL,"Novo Nordisk Inc",NJ,100000000144,12.69,04/16/2014,GNRL,161285666
107296,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,12.62,04/03/2015,GNRL,275832552
107296,GNRL,"Novo Nordisk Inc",NJ,100000000144,12.61,10/11/2014,GNRL,162135058
107296,GNRL,"Novo Nordisk Inc",NJ,100000000144,12.57,12/02/2014,GNRL,162217134
107296,GNRL,"Novo Nordisk Inc",NJ,100000000144,12.55,01/27/2015,GNRL,266055156
107296,GNRL,"Astellas Pharma US Inc",IL,100000000137,12.54,01/23/2015,GNRL,294798990
107296,GNRL,"Astellas Pharma US Inc",IL,100000000137,12.21,11/21/2014,GNRL,168544110
107296,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.12,01/21/2015,GNRL,260124040
107296,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.09,07/23/2014,GNRL,149967526
107296,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,11.97,04/11/2014,GNRL,199574773
107296,GNRL,"Novo Nordisk Inc",NJ,100000000144,11.97,01/06/2015,GNRL,265966528
107296,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,11.96,01/22/2014,GNRL,187735614
107296,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,11.91,01/26/2015,GNRL,331495874
107296,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,11.83,10/29/2014,GNRL,198743958
107296,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.73,01/08/2015,GNRL,260115124
107296,GNRL,"Novo Nordisk Inc",NJ,100000000144,11.69,04/24/2014,GNRL,162217098
107296,GNRL,"Meda Pharmaceuticals, Inc.",NJ,100000011184,11.69,08/08/2014,GNRL,221162858
107296,GNRL,"Lilly USA, LLC",IN,100000000066,11.69,02/12/2015,GNRL,268176796
107296,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.55,04/14/2014,GNRL,150505815
107296,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.55,03/11/2015,GNRL,260119944
107296,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.54,08/13/2014,GNRL,149813773
107296,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,11.46,02/26/2015,GNRL,336909044
107296,GNRL,"Novo Nordisk Inc",NJ,100000000144,11.38,06/02/2014,GNRL,161699946
107296,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.35,09/17/2014,GNRL,150528252
107296,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,11.21,08/25/2014,GNRL,188041538
107296,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.10,03/30/2015,GNRL,260117526
107296,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,10.84,05/20/2014,GNRL,187893128
107296,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,10.78,07/29/2014,GNRL,187989336
107296,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,10.76,08/06/2014,GNRL,156892748
107296,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,10.75,10/27/2014,GNRL,188122646
107296,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,10.71,07/08/2014,GNRL,199574770
107296,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.56,06/12/2014,GNRL,149453302
107296,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.47,06/27/2014,GNRL,148154978
107296,GNRL,"Novo Nordisk Inc",NJ,100000000144,10.39,11/03/2014,GNRL,162156644
107296,GNRL,"Mylan Specialty L.P.",WV,100000005573,10.37,09/09/2014,GNRL,186091466
107296,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,10.22,10/15/2014,GNRL,202188042
107296,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,9.60,11/17/2014,GNRL,188154352
107296,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,9.41,07/21/2014,GNRL,156892738
107296,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,9.41,06/04/2014,GNRL,156892730
107296,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,8.32,08/12/2014,GNRL,201943546
107296,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,7.91,10/02/2014,GNRL,156892726
107296,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,7.59,12/11/2014,GNRL,202587896
107296,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,7.07,06/18/2014,GNRL,201802296
107296,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,6.93,11/11/2014,GNRL,202467186
107296,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,6.75,07/24/2014,GNRL,201879806
107296,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,6.62,07/16/2014,GNRL,201859346
107296,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,5.95,05/23/2014,GNRL,201763132
107296,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,5.79,03/04/2015,GNRL,336921002
107296,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,5.78,08/20/2014,GNRL,201977448
107296,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,5.63,06/26/2014,GNRL,156892732
107296,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,5.49,07/01/2014,GNRL,201904904
107296,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,5.45,08/28/2014,GNRL,202036344
107296,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,5.26,12/15/2014,GNRL,202651529
107296,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,5.12,06/17/2014,GNRL,201835482
107296,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,4.85,08/25/2014,GNRL,156892740
107296,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,4.83,11/18/2014,GNRL,202535614
107296,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,4.65,10/20/2014,GNRL,202369846
107296,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,4.65,09/12/2014,GNRL,202166484
107296,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,4.59,06/10/2014,GNRL,201777098
107296,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,3.45,10/27/2014,GNRL,156892744
107296,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,3.26,03/30/2015,GNRL,337046548
107296,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,2.80,11/04/2014,GNRL,202464870
107296,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,0.89,06/23/2014,GNRL,187934010
107296,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,0.71,06/18/2014,GNRL,201784288
107296,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,0.56,11/17/2014,GNRL,188154136
